Table 1.
Baseline Characteristics of Disease Groups
| CML (N=82) |
Myelofibrosis (N=19) |
Aplastic Anemia (N=30) |
p-value | |
|---|---|---|---|---|
|
| ||||
| Age (years) | 42+1 | 56+1 | 35±3 | < 0.001 |
|
| ||||
| Race (Caucasian/African-American/Asian/Hispanic/Other) | 68/9/1/2/2 | 19/0/0/0/0 | 27/1/0/0/2 | 0.5 |
|
| ||||
| Gender (Female/Male) | 41/41 | 8/11 | 16/14 | 0.7 |
|
| ||||
| Hemoglobin (g/dL) | 11.8±0.2 | 9.3±0.4 | 9.1±0.3 | <0.001 |
|
| ||||
| WBC (k/μL) | 14.4±2.6 | 21.1±5.3 | 0.8±0.2 | 0.005 |
|
| ||||
| RBC (m/μL) | 3.8±0.1 | 3.3±0.2 | 3.0±0.1 | <0.001 |
|
| ||||
| Hematocrit (%) | 35.6±0.6 | 29.1±1.3 | 25.7±0.9 | <0.001 |
|
| ||||
| MCV (fL) | 94.8±1.0 | 88.6±1.8 | 86.2±1.5 | <0.001 |
|
| ||||
| MCH (pG) | 31.2±0.4 | 28.3±0.8 | 29.2±1.2 | 0.02 |
|
| ||||
| MCHC (g/dL) | 33.2±0.1 | 31.9±0.4 | 35.3±0.1 | <0.001 |
|
| ||||
| RDW (%) | 16.7±0.4 | 19.8±0.7 | 16.3±0.7 | <0.001 |
|
| ||||
| Platelet Count (k/μL) | 269±28 | 264±65 | 18±2 | <0.001 |
|
| ||||
| FEV1 (%) | 91±2 | 87±3 | 94±3 | 0.2 |
|
| ||||
| FVC (%) | 97±2 | 89±3 | 98±3 | 0.03 |
|
| ||||
| FEV1/FVC | 78±1 | 78±1 | 79±1 | 0.7 |
|
| ||||
| DLCO (%) | 86±2 | 73±3 | 64±4 | <0.001 |
|
| ||||
| DLCOc (%)* | 91±3 | 84±4 | 82±4 | 0.2 |
*
DLCOc, Diffusion of carbon monoxide corrected for hemoglobin concentration.